Image

High Velocity Resistance Training Versus Otago Exercise Training on Falling Risk in Elderly

High Velocity Resistance Training Versus Otago Exercise Training on Falling Risk in Elderly

Recruiting
65 years and older
All
Phase N/A

Powered by AI

Overview

The study aim is to find out the difference between applying the otago exercise training versus high velocity resisted training on risk of fall in elderly. There will be no significant difference between the effect of otago exercise program versus high velocity resisted training on risk of fall in elderly . 40 Old aged persons of both sex their age \>65 years and have risk of falling will be recruited in this study.

Description

Type of study : Randomized trail This prospective interventional study that will be conducted on 40 case of both sex their age above 65

They randomly assigned into 2 equal groups:

Study group (A) 20 patients will receive otago exercise program and will do their normal activity of daily living. Study group (B) 20 patients will receive high velocity resisted training and will do their normal activity of daily living

Eligibility

Inclusion Criteria:

  • Age \>65 years old.
  • Both sex.
  • Have limited their activity level due to concern about falling (with or without falling) score by short -FES \> 7 and by
  • fall risk check list ≥ 4.
  • Participants will be independently ambulating

Exclusion Criteria:

  • Any uncontrolled non musculoskeletal conditions that would make testing difficult and uncomfortable such as chronic obstructive airways disease and/or congestive heart failure.
  • A pre-existing neurological condition that affects lower-limb strength, balance and or ambulation (e.g., polio, stroke).
  • Any uncontrolled musculoskeletal or orthopedic conditions that may affect ambulation (e.g. rheumatoid arthritis).
  • Severe cerebrovascular or peripheral venous insufficiency.
  • History of surgery within the past 6 weeks.
  • Sensory impairments (vision, hearing, etc.) that affect communication
  • Previous diagnosis of dementia.
  • Hypotension (systolic blood pressure \<90 mmHg, diastolic blood pressure \<60 mmHg

Study details
    Falling Risk

NCT07204808

Beni-Suef University

31 January 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.